|
Binimetinib Clinical Trials
11 actively recruiting trials across 7 locations
▼ -2 trials since June 2026
Also known as: ARRY 162, ARRY 438162, ARRY-162, ARRY-438162, ARRY162 +8 more
Pipeline
Phase 1: 2Phase 2: 6Phase 3: 1Phase 1/2: 1
Top Sponsors
- National Cancer Institute (NCI)2
- University of California, San Francisco1
- UNICANCER1
- SWOG Cancer Research Network1
- Rina Plattner1
Indications
- Cancer11
- Metastatic Melanoma3
- Melanoma Stage III2
- Melanoma Stage IV2
- Pathologic Stage IV Cutaneous Melanoma AJCC v82
Other3 trials
Birmingham, Alabama2 trials
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
University of Alabama at Birmingham Cancer Center
Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
University of Alabama at Birmingham Cancer Center
Phase 2
Fayetteville, Arkansas1 trial
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Highlands Oncology Group
Phase 1
La Jolla, California1 trial
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
UC San Diego Moores Cancer Center
Phase 2
Los Angeles, California1 trial
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
UCLA Medical Center
Phase 1/2
Iowa City, Iowa1 trial
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
University of Iowa
Phase 1
Bethesda, Maryland1 trial
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
National Institutes of Health Clinical Center
Phase 2
Houston, Texas1 trial
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
M D Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.